Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01603992 · ClinicalTrials.gov registry record
Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms
A clinical trial of Cannabis Dependence and Cannabis Abuse, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 822
- Enrollment target
- 3
- Study locations
NCT01603992 is a study of Cannabis Dependence and Cannabis Abuse that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 822 participants, above the 62-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (1226% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT01603992, a study of Cannabis Dependence and Cannabis Abuse, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 822 participants
- Enrollment target
- 3
- Study locations
Study Summary
Background: \- Marijuana is the most widely used illicit drug in the world, yet relatively little is known about users who try to quit without formal treatment ( spontaneous quitting). Studies have suggested that there are some common strategies that many individuals use in spontaneous quitting, such as changing one s lifestyle or identity, reminding oneself of negative consequences, support from family and friends, and religion. However, more research is needed to determine potential treatment strategies for marijuana use. Objectives: * To identify strategies used to help with marijuana quitting among non-treatment seeking adult marijuana users. * To identify withdrawal symptoms experienced during marijuana quitting and their relationship to the quitting strategies used and the outcome of the quit attempt. * To evaluate whether subgroups of marijuana users differ in their experience of marijuana quitting. Eligibility: \- Individuals at least 18 years of age who have made at least one attempt to quit marijuana use. Design: * The study will consist of one visit of approximately 1 to 2 hours. * Participants will fill out three questionnaires. The questionnaires have different types of questions, and will ask about background and lifestyle, marijuana use and craving patterns and behaviors, and difficulties in previous attempts to quit using marijuana.
Conditions Studied
Study Locations (3)
Maryland
- National Institute on Drug Abuse, Biomedical Research Center (BRC) - Baltimore
- Maryland Psychiatric Research Center (MPRC) 55 Wade Avenue - Catonsville
South Carolina
- Medical University of S. Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 822 participants |
| Start Date | 2005-11-08 |
| Est. Completion | 2012-05-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01603992
The ClinicalTrials.gov registry entry for NCT01603992 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 822 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 62-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (1226% higher). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cannabis Dependence appearing as the primary indexed condition, and to 0 interventions.
NCT01603992 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Maryland, South Carolina.
Frequently Asked Questions
What is clinical trial NCT01603992 about?
NCT01603992 is a clinical study titled "Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms". Background: \- Marijuana is the most widely used illicit drug in the world, yet relatively little is known about users who try to quit without formal treatment ( spontaneous quitting). Studies have suggested that there are some common strategies that many individuals use in spontaneous quitting, su...
What is the current status of trial NCT01603992?
This trial is currently completed. The enrollment target is 822 participants. The study started on 2005-11-08. Estimated completion is 2012-05-03.
What conditions does trial NCT01603992 study?
This clinical trial studies the following conditions: Cannabis Dependence, Cannabis Abuse.
Who is sponsoring clinical trial NCT01603992?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01603992 being conducted?
This trial has 3 study locations across Maryland, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
RECRUITING
-
Neuroimaging of Adolescent Cannabis Use Treatment
RECRUITING · NA
-
Breathwork-assisted Treatment for Cannabis Use Disorder
ACTIVE NOT RECRUITING · NA
-
Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine
COMPLETED · Phase 4
-
Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders
COMPLETED · NA
-
Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.